Metraipolis › archive › dc_de2399450ff5

Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42141012
DOI
10.1038/s41598-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T06:13:00.985Z
SHA-256 of the archived text
1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25
Stable URL of this page
https://metraipolis.com/documento/dc_de2399450ff5

How to cite

Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012 — Europe PMC (en), https://europepmc.org/article/MED/42141012 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de2399450ff5 (Metraipolis archive dc_de2399450ff5, sha256 1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25)
BibTeX
@misc{dcde2399450ff5,
  title = {Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized,… — Europe PMC PMID:42141012},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42141012},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de2399450ff5; sha256 1248fdee637f24dbdbbd19d33ecf5a03108a4693ddf8cb9046ecaf0346ebcb25},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42141012. Agents can read the archived copy with the MCP tool read_document.